Tuesday, January 10, 2012 7:52:29 AM
Some interesting DD,it seems that Mark Dyne on ATRN BOD has deep connections to BDLN as both he and the chairman of BDLN both worked together in senior management at SEGA at the same time. Mark Dyne, runs Europlay Capital. These guys can raise all kinds of cash. Here is a quote and a link.
http://europlaycapital.com/
10th May 2011 Europlay Capital Advisors LLC. represents founders of Skype in a sale to Microsoft.
REDMOND, Wash., and LUXEMBOURG - May 10, 2011 - Microsoft Corp. (Nasdaq: "MSFT") and Skype Global S.àr.l today announced that they have entered into a definitive agreement under which Microsoft will acquire Skype, the leading Internet communications company, for $8.5 billion in cash from the investor group led by Silver Lake. The agreement has been approved by the boards of directors of both Microsoft and Skype.
http://europlaycapital.com/
10th May 2011 Europlay Capital Advisors LLC. represents founders of Skype in a sale to Microsoft.
REDMOND, Wash., and LUXEMBOURG - May 10, 2011 - Microsoft Corp. (Nasdaq: "MSFT") and Skype Global S.àr.l today announced that they have entered into a definitive agreement under which Microsoft will acquire Skype, the leading Internet communications company, for $8.5 billion in cash from the investor group led by Silver Lake. The agreement has been approved by the boards of directors of both Microsoft and Skype.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
